Resuscitative endovascular balloon occlusion of the aorta

CoTCCC Includes the AAJT-S by Compression Works for Junctional Hemorrhage Use

Retrieved on: 
Thursday, November 4, 2021
Journal of Surgical Research, Groin, Resuscitative endovascular balloon occlusion of the aorta, Abdominal aortic aneurysm, EMS, CEO, Institute, Department, Technology, Multi-junction solar cell, United, USA, Standard of care, ISR, Bleeding, Unconventional warfare (United States Department of Defense doctrine), Gaps, Axilla, Committee, Publication, Injury, Tactical Combat Casualty Care, Trauma, Patient, Literature, FDA, TCCC, Surgeon, REBOA, Hospital, Birth control, Medical device

The AAJT-S by Compression Works is used to treat non-compressible hemorrhages by U.S. special operations units, army units and allied special operations partners globally.

Key Points: 
  • The AAJT-S by Compression Works is used to treat non-compressible hemorrhages by U.S. special operations units, army units and allied special operations partners globally.
  • The Compression Works device is also featured in over 64 peer reviewed publications in the literature.
  • Compression Works is the developer and manufacturer of the Abdominal Aortic and Junctional Tourniquet-Stabilized (AAJT-S) medical device.
  • Compression Works is a veteran owned business dedicated to saving lives on and off the battlefield.

Prytime Medical™ Launches New ER-REBOA™ PLUS Catheter

Retrieved on: 
Thursday, September 17, 2020
Surgery, Health, Medical devices, Bleeding, Interventional radiology, Resuscitative endovascular balloon occlusion of the aorta, Catheter, Medical specialties, Todd Rasmussen, Clinical medicine

Prytime Medical Devices, Inc. introduced its latest aortic occlusion catheter, the ER-REBOA PLUS this week at the American Association for the Surgery of Trauma (AAST) Annual Meeting.

Key Points: 
  • Prytime Medical Devices, Inc. introduced its latest aortic occlusion catheter, the ER-REBOA PLUS this week at the American Association for the Surgery of Trauma (AAST) Annual Meeting.
  • ER-REBOA PLUS represents the evolution of REBOA based on experience and input from civilian trauma surgeons, said David Spencer, CEO, Prytime.
  • The ER-REBOA PLUS catheter was developed to help doctors preserve their clinical options for optimal care and best outcomes.
  • To learn more about Prytime Medical and the ER-REBOA PLUS Catheter, go to www.prytimemedical.com or call (210) 340-0116.

Medical Device Executive Nelson Whistance Joins Gynesonics As Vice President of U.S. Sales

Retrieved on: 
Monday, August 17, 2020
Medical devices, Health, Consumer, Surgery, Women, Other Health, Medicine, Clinical medicine, Health, Interventional radiology, Medical terminology, Gynaecological neoplasia, RTT, Uterine fibroid, Resuscitative endovascular balloon occlusion of the aorta, Minimally invasive procedure, Sonata System, Gynesonics

Gynesonics, a womens healthcare company focused on the development of minimally-invasive solutions for symptomatic uterine fibroids, announced today that medical device executive Nelson Whistance has been named Vice President of U.S.

Key Points: 
  • Gynesonics, a womens healthcare company focused on the development of minimally-invasive solutions for symptomatic uterine fibroids, announced today that medical device executive Nelson Whistance has been named Vice President of U.S.
  • Nelson is a proven sales leader that has spent the majority of his medical device career driving commercial business in minimally invasive gynecologic surgery.
  • Previously, Mr. Whistance was Vice President of Sales and Marketing for Prytime Medical Devices, supporting the commercial market adoption of the ER-REBOA Catheter portfolio.
  • Mr. Whistance has held various sales and leadership roles for American Medical Systems, Servier Canada Pharmaceuticals and Sysco Edmonton.

PRYTIME MEDICAL™ Celebrates 500th Documented Life Saved

Retrieved on: 
Thursday, December 5, 2019
Medicine, Interventional radiology, Bleeding, Clinical medicine, Resuscitative endovascular balloon occlusion of the aorta, Medical terminology, Catheter, Minimally invasive procedure, Todd Rasmussen

SAN ANTONIO, Dec. 5, 2019 /PRNewswire-PRWeb/ -- PRYTIME MEDICAL today announced the 500th documented life saved using the ER-REBOA Catheter.

Key Points: 
  • SAN ANTONIO, Dec. 5, 2019 /PRNewswire-PRWeb/ -- PRYTIME MEDICAL today announced the 500th documented life saved using the ER-REBOA Catheter.
  • "The ER-REBOA Catheter has now played a role in 500 documented lives saved," said David Spencer, CEO of Prytime.
  • To learn more about Prytime Medical and the ER-REBOA Catheter, click here: http://www.prytimemedical.com
    Prytime Medical Devices, Inc. designs, develops and commercializes minimally invasive solutions for hemorrhage control.
  • Dr. Rasmussen who commented for this press release has no financial relationship with and receives no payments from Prytime Medical.

Prytime Medical™ Devices, Inc. Launches STAAR (Simulation Trainer for Arterial Access and REBOA) to Support Global Training

Retrieved on: 
Thursday, August 22, 2019
Bleeding, Resuscitative endovascular balloon occlusion of the aorta, Femoral artery, Catheter, Medicine, Medical specialties, Clinical medicine, Endovascular and hybrid trauma and bleeding management

SAN ANTONIO, August 22, 2019 /PRNewswire-PRWeb/ --Prytime Medical Devices Inc., today announced the launch of the Prytime Medical STAAR (Simulation Trainer for Arterial Access and REBOA).

Key Points: 
  • SAN ANTONIO, August 22, 2019 /PRNewswire-PRWeb/ --Prytime Medical Devices Inc., today announced the launch of the Prytime Medical STAAR (Simulation Trainer for Arterial Access and REBOA).
  • Therefore, arterial access and catheter placement training is essential to improve speed and precision; this is an important part of any ER-REBOA program.
  • "Simulation training has become a critically important tool for surgical skills training, particularly with procedures such as REBOA, said Dr. Bradley Dennis, Associate Professor of Surgery at Vanderbilt University Medical Center.
  • The Prytime Medical STAAR consists of a pulsatile flow loop that simulates a patient's blood pressure and flow, as well as an ultrasound compatible access patch to visualize key anatomy such as the common femoral artery for arterial access training.

Prytime Medical Devices, Inc. Expands Global Market of Life-Saving Medical Device

Retrieved on: 
Tuesday, April 2, 2019
Bleeding, Medical device, Resuscitative endovascular balloon occlusion of the aorta, Catheter

"Formalizing new distribution channels is another positive step in our global expansion plans," said David Spencer, President and Chief Executive Officer of Prytime Medical Devices.

Key Points: 
  • "Formalizing new distribution channels is another positive step in our global expansion plans," said David Spencer, President and Chief Executive Officer of Prytime Medical Devices.
  • "As a small company, we are proud of the impact our product has made providing medical personnel a tool to stop bleeding."
  • Spencer is co-founder of the medical technology company, and known for his passion for technology commercialization and economic development.
  • "Our company's strategic alliance with distributors expands availability of the ER-REBOA Catheter in the global marketplace," said David G. Baer, Ph.D., Vice President of Market Development at Prytime Medical Devices.